KA
Kineta Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
proteostasis therapeutics is discovering and developing novel small molecule therapeutics designed to control the body’s protein homeostasis, or proteostasis network. the proteostasis network maintains the body’s natural balance of proteins to protect us from numerous diseases. these novel therapies, or proteostasis regulators, are designed to treat multiple genetic and degenerative disorders associated with deficiencies of the proteostasis network, such as alzheimer’s disease, emphysema, huntington’s disease, and type ii diabetes.
Market Cap: 8.11 Million
Primary Exchange: NASDAQ
Website: http://www.proteostasis.com/
Shares Outstanding: 10.4 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 1.1401496792953352
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 295 trading days
From: 2023-02-07 To: 2024-03-07
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|---|---|---|---|---|---|---|---|
| 2022-12-16 | 2022-12-19 | 2022-12-15 | 2022-12-05 | 1.43 | Cash | |||
| 2022-12-19 | 2022-12-19 | 2022-12-15 | 2022-12-05 | 1.43 | Cash |
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|